• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

COVID-19 and Cardiovascular Disease: Clinical Guidance for Primary Care

Slideshow

The case fatality rate for patients with COVID-19 and CVD is higher than for cancer, chronic respiratory disease, and diabetes. Here is current guidance from the ACC.

The reported case fatality rate for patients with COVID-19 infection who have underlying cardiovascular disease (CVD) is approximately 10% -- higher than for cancer, chronic respiratory disease, and diabetes. The American College of Cardiology recently published a clinical bulletin titled "COVID-19 Clinical Guidance for the CV Care Team." The majority of the information is also highly relevant for primary care physicians who routinely see patients with a full range of CVD and related morbidity.Click through the short slide show below for a summary of the bulletin curated for primary care.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.